ECSP077283A - Agente antiprotozoario - Google Patents

Agente antiprotozoario

Info

Publication number
ECSP077283A
ECSP077283A EC2007007283A ECSP077283A ECSP077283A EC SP077283 A ECSP077283 A EC SP077283A EC 2007007283 A EC2007007283 A EC 2007007283A EC SP077283 A ECSP077283 A EC SP077283A EC SP077283 A ECSP077283 A EC SP077283A
Authority
EC
Ecuador
Prior art keywords
agent
antiprotozoary
present
antiprotozoal
antiprotozoal agent
Prior art date
Application number
EC2007007283A
Other languages
English (en)
Inventor
Hiroyuki Fuchino
Setsuko Sekita
Marii Takashi
Motoyoshi Satake
Original Assignee
Japan Health Sciences Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Health Sciences Foundation filed Critical Japan Health Sciences Foundation
Publication of ECSP077283A publication Critical patent/ECSP077283A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/30Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • A61K31/122Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232Angelica
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención provee un agente antiprotozoarios, el cual, es preferido, particularmente, como un agente antileishmaniático. La presente invención está, específicamente, direccionado a un agente antiprotozoarios que comprende, como un ingrediente activo, un compuesto de Fórmula (I): donde R es -H ó acilo, una sal del mismo o solvato del mismo.
EC2007007283A 2004-07-30 2007-02-28 Agente antiprotozoario ECSP077283A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2004223485 2004-07-30

Publications (1)

Publication Number Publication Date
ECSP077283A true ECSP077283A (es) 2007-03-29

Family

ID=35786144

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2007007283A ECSP077283A (es) 2004-07-30 2007-02-28 Agente antiprotozoario

Country Status (8)

Country Link
US (1) US20080254136A1 (es)
EP (1) EP1779892A4 (es)
JP (1) JP4899002B2 (es)
CN (1) CN101048154A (es)
BR (1) BRPI0513951A (es)
EC (1) ECSP077283A (es)
IL (1) IL180956A0 (es)
WO (1) WO2006011394A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010512382A (ja) * 2006-12-12 2010-04-22 ジン−ド カウンティー シコニン系化合物を含む糖尿病予防及び治療のための医薬組成物、並びにその用途
JP4762381B1 (ja) 2010-10-19 2011-08-31 学校法人青山学院 抗リーシュマニア化合物及び抗リーシュマニア薬

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5653529B2 (es) * 1972-09-18 1981-12-19
GB8310140D0 (en) * 1983-04-14 1983-05-18 Wellcome Found Antiprotozoal agents
GB8310141D0 (en) * 1983-04-14 1983-05-18 Wellcome Found Naphthoquinone derivatives
AU633836B2 (en) * 1988-08-16 1993-02-11 Wellcome Foundation Limited, The Medicaments
GB8819477D0 (en) * 1988-08-16 1988-09-21 Wellcome Found Medicaments
EP0395294A3 (en) * 1989-04-25 1991-05-22 Takeda Chemical Industries, Ltd. Control of protozoal disease
JPH10212230A (ja) * 1997-01-29 1998-08-11 Kureha Chem Ind Co Ltd Hsp60ファミリーに属するタンパク質のジヒドロキシナフトキノン化合物含有合成抑制剤
JP2002212065A (ja) * 2001-01-23 2002-07-31 Univ Showa チロシンキナーゼ阻害剤及び医薬組成物
JP2004075613A (ja) * 2002-08-19 2004-03-11 Club Cosmetics Co Ltd 保湿剤及び皮膚外用剤並びにシコン抽出物の使用方法
JP2004091386A (ja) * 2002-08-30 2004-03-25 Club Cosmetics Co Ltd 外用皮膚潰瘍治療剤及び皮膚潰瘍治療用キット並びにシコン抽出物の使用方法
EP1417886A1 (en) * 2002-11-06 2004-05-12 Ciba SC Holding AG Substituted phenols as useful repellents for insects

Also Published As

Publication number Publication date
WO2006011394A1 (ja) 2006-02-02
IL180956A0 (en) 2007-07-04
EP1779892A4 (en) 2010-05-19
CN101048154A (zh) 2007-10-03
US20080254136A1 (en) 2008-10-16
JP4899002B2 (ja) 2012-03-21
EP1779892A1 (en) 2007-05-02
JPWO2006011394A1 (ja) 2008-05-01
BRPI0513951A (pt) 2008-05-20

Similar Documents

Publication Publication Date Title
CR11688A (es) Compuesto heterociclico
CR20120345A (es) Derivados de 3-hidroxi-5-arilisotiazol novedosos
CR9753A (es) Agente terapeutico para diabetes
CY1112722T1 (el) Μυκητοκτονες συνθεσεις
UY32730A (es) Inhibidores de cyp17
CR10748A (es) Compuesto de indol
CR20110492A (es) Compuestos tetracíclicos
CR20120190A (es) INHIBIDORES DE N1-PIRAZOLOESPIROCETONA ACETIL-CoA CARBOXILASA
CO6592104A2 (es) Compuesto heterociclico
BR112014017749A8 (pt) Composto alquinilbenzeno 3,5-dissubstituído e sal do mesmo
GEP20146003B (en) Benzothiazole derivatives as anticancer agents
SV2006002187A (es) Indazoles utiles para tratamientos de enfermedades cardiovasculares ref.wyth0089-504(am101590)
CY1115902T1 (el) Συνδυαστικη θεραπεια καρκινου με ανασταλτικες ενωσεις hps90
UY32045A (es) Compuesto amida
CO6531452A2 (es) Piperidinas sustituidas que aumentan la actividad de p53 y sus usos
ECSP20023626A (es) Novedosos derivados de pirazolo-pirrolo-pirimidina como inhibidores de p2x3
UY30451A1 (es) 18-metil-19-nor-androst-4-en-17,17-espiroéteres (18-metil-19-nor-20-espirox-4-en-3-onas),ase como preparaciones farmacéuticas que lo contienen.
PA8667201A1 (es) Nuevos compuestos farmaceuticos
MX2009006118A (es) Composicion para el cuidado personal que comprende un elastomero de silicona.
CO6382105A2 (es) Agente preventivo/terapéutico contra el cancer
HN2010000330A (es) DERIVADOS DE INDOL-2-ONA DISUSTITUIDOS EN 3 y SU PREPARACION
BRPI0713743C1 (pt) composto, e, composição farmacêutica
GT200700057A (es) Nuevos derivados de piridazina
CO6430466A2 (es) Derivados de pirazolopirimidina triciclicos
ECSP088374A (es) Formulacion de aerosol para inhalacion